Document is current
Any future updates will be listed below
-
Authors
Xie, Junqing https://orcid.org/0000-0002-0040-0042
Feng, Shuo https://orcid.org/0000-0001-7855-0991
Li, Xintong
Gea-MallorquÃ, Ester https://orcid.org/0000-0002-6915-074X
Prats-Uribe, Albert https://orcid.org/0000-0003-1202-9153
Prieto-Alhambra, Dani https://orcid.org/0000-0002-3950-6346
- License Information
-
More Information
Article History
Received: 20 October 2021
Accepted: 24 February 2022
First Online: 21 March 2022
Competing interests
: DPA reported receiving grant support from Les Laboratoires Servier; that his research group has received grants and advisory or speaker fees from Amgen, Astellas, AstraZeneca, Chesi-Taylor, Johnson and Johnson and UCD; and that Janssen, on behalf of Innovative Medicines Initiative-funded European Health Data Evidence Network and European Medical Information Framework consortium and Synapse Management Partners, has supported training programs, open to external participants, organized by his department. Others have nothing to disclose.
